References / Acknowledgements

1 Pluznik DH, Sachs L: The cloning of normal ‘mast’ cells in tissue culture. J Cell Physiol 1965; 66: 319–324. 2 Bradley TR, Metcalf D: The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 1966; 44: 287–299. 3 Sutherland HJ, Lansdorp PM, Henkelman DH, Eaves AC, Eaves CJ: Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 1990; 87: 3584–3588. 4 Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, et al: Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180–191. 5 Lapidot T, Fajerman Y, Kollet O: Immunedefi cient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis. J Mol Med 1997; 75: 664–673. 6 Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG: Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004; 304: 104–107. 7 Ugo V, Marzac C, Teyssandier I, Larbret F, Lecluse Y, Debili N, Vainchenker W, Casadevall N: Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera. Exp Hematol 2004; 32: 179–187. 8 Moretti S, Dabusti M, Castagnari B, Tieghi A, Ferrari L, Campioni D, Punturieri M, Dominici M, Castoldi GL, Lanza F: Comparison of single and dual platform methodologies for the estimation of CD34+ hematopoietic progenitor cells: Correlation with colony assay. Int J Biol Markers 2002; 17: 259–267. 9 Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS, Nugent DJ: Immune thrombocytopenic purpura (ITP) plasma and purifi ed ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 2003; 102: 887–895. 10 Berthier R, Valiron O, Schweitzer A, Marguerie G: Serum-free medium allows the optimal growth of human megakaryocyte progenitors compared with human plasma supplemented cultures: Role of TGF beta. Stem Cells 1993; 11: 120–129. 11 Dobo I, Mossuz P, Campos L, Girodon F, Allegraud A, Latger-Cannard V, Boiret N, Pineau D, Wunder E, Zandecki M, Praloran V, Hermouet S: Comparison of four serum-free, cytokine-free media for analysis of endogenous erythroid colony growth in polycythemia vera and essential thrombocythemia. Hematol J 2001; 2: 396–403. 12 Dobo I, Donnard M, Girodon F, Mossuz P, Boiret N, Boukhari R, Allegraud A, Bascans E, Campos L, Pineau D, Turlure P, Praloran V, Hermouet S: Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera. Hematol J 2004; 5: 161–167. 13a Iscove NN, Senn JS, Till JE, McCulloch EA: Colony formation by normal and leukemic human marrow cells in culture: Effect of conditioned medium from human leukocytes. Blood 1971; 37: 1–5. 13b Iscove NN: Culture of lymphocytes and hemopoietic cells in serum-free medium; in Darnes D, Sirbascu D, Sato G (eds): Methods for Serum-Free Cultures of Neuronal and Lymphoid Cells. New York, Alan Liss, 1984, pp 169– 185. 14 Zeuner A, Pedini F, Signore M, Testa U, Pelosi E, Peschle C, De Maria R: Stem cell factor protects erythroid precursor cells from chemotherapeutic agents via up-regulation of BCL-2 family proteins. Blood 2003; 102: 87–93. 15 Vainchenker W, Bouguet J, Guichard J, Breton-Gorius J: Megakaryocyte colony formation from human bone marrow precursors. Blood 1979; 54: 940–945. 16 Hogge D, Fanning S, Bockhold K, Petzer A, Lambie K, Lansdorp P, Eaves A, Eaves C: Quantitation and characterization of human megakaryocyte colony-forming cells using a standardized serum-free agarose assay. Br J Haematol 1997; 96: 790–800. 17 Niittyvuopio R, Juvonen E, Kekomaki R, Oksanen K, Anttila P, Ruutu T: The predictive value of megakaryocytic and erythroid colony formation and platelet function tests on the risk of thromboembolic and bleeding complications in essential thrombocythaemia. Eur J Haematol 2004; 72: 245–251. 18 McAdams TA, Miller WM, Papoutsakis ET: Variations in culture pH affect the cloning effi ciency and differentiation of progenitor cells in ex vivo haemopoiesis. Br J Haematol 1997; 97: 889–895. 19 Broughton CM, Sherrington P, Pender NT, Clark RE: Molecular status of individual CFUGM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia. Genes Chromosomes Cancer 1997; 18: 292–298. 20 Dobo I, Bidet JM, Acquart S, Allegraud A, Amiot L, Boccaccio C, Boiret N, Domenech J, Mossuz P, Sensebe L, Wunder E, Zandecki M, Hermouet S: Reproducible scoring of CFUGM and BFU-E grown in collagen-based semisolid medium after a short (3 h) training. J Hematother 1999; 8: 45–51. 21 Horner S, Pasternak G, Hehlmann R: A statistically signifi cant sex difference in the number of colony-forming cells from human peripheral blood. Ann Hematol 1997; 74: 259–263. 22 Sallerfors B, Olofsson T: Cell-mediated inhibition of granulopoiesis in vitro in patients with acute myeloid leukemia in remission. Eur J Haematol 1989; 42: 164–172. 23 Chang J, Geary CG, Testa NG: Long-term bone marrow damage after chemotherapy for acute myeloid leukaemia does not improve with time. Br J Haematol 1990; 75: 68–72. 24 Betticher DC, Huxol H, Muller R, Speck B, Nissen C: Increased colony growth in peripheral blood cultures from patients with ALL depends on immunological subtype. Eur J Haematol 1993; 51: 109–112. 25 Messner HA, Curtis JE, Minden MD, Tritchler D, Lockwood G, Takahashi T, Lepine J, Jamal N, Tweeddale M, Wandl U: Clonogenic hemopoietic precursors in bone marrow transplantation. Blood 1987; 70: 1425–1432. 26 Podesta M, Piaggio G, Frassoni F, Pitto A, Mordini N, Bregante S, Valeriani A, Bacigalupo A: Defi cient reconstitution of early progenitors after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 1011–1017. 27 Nissen C, Cornu P, Weber W, Speck B: Differential diagnosis of primary and secondary erythrocytosis by means of in vitro culture of hematopoietic stem cells. Schweiz Med Wochenschr 1978; 108: 1581–1583. 28 Correa PN, Eskinazi D, Axelrad AA: Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: Studies in an improved serumfree medium. Blood 1994; 83: 99–112. 29 Weinberg RS, Worsley A, Gilbert HS, Cuttner J, Berk PD, Alter BP: Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: Only polycythemia vera has endogenous colonies. Leuk Res 1989; 13: 331–338. 30 Chalandon Y, Jiang X, Hazlewood G, Loutet S, Conneally E, Eaves A, Eaves C: Modulation of p210(BCR-ABL) activity in transduced primary human hematopoietic cells controls lineage programming. Blood 2002; 99: 3197– 3204. 31 Cremer I, Dieu-Nosjean MC, Marechal S, Dezutter-Dambuyant C, Goddard S, Adams D, Winter N, Menetrier-Caux C, Sautes-Fridman C, Fridman WH, Mueller CG: Long-lived immature dendritic cells mediated by TRANCERANK interaction. Blood 2002; 100: 3646– 3655. 32 Kern P, Heimpel H, Heit W, Kubanek B: Granulocytic progenitor cells in aplastic anaemia. Br J Haematol 1977; 35: 613–623. 33 Saunders EF, Freedman MH: Constitutional aplastic anaemia: Defective haematopoietic stem cell growth in vitro. Br J Haematol 1978; 40: 277–287.